Stock Spotlight Archives - Page 152 of 383

WednesdayOct 13, 2021 2:58 pm

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Expands Footprint, GMP Certifications to Three

Flora Growth (NASDAQ: FLGC) is currently seeking revenue-generating acquisitions and strategic partnerships that offer a larger distribution network, amplify revenue growth and complement its human capital. “In recent months, Flora has announced three major transactions — Vessel Brand, Koch & Gsell, and Hoshi International,” reads a recent article. The acquisition of Vessel Brand is expected to expand Flora’s premium brand and product portfolio while diversifying its global distribution channels. The acquisition of Koch & Gsell, which is expected to introduce Flora Growth’s products to the Swiss, European and Asian markets, promises to bring patented hemp cigarette manufacturing technology into new…

WednesdayOct 13, 2021 2:35 pm

QualityStocksNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Leveraging State-of-the-Art Facilities, Expertise in Rapidly Growing Market

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, is in a position to leverage its state-of-the-art facilities and expertise to manufacture its own beverage product lines and to provide white-label solutions to a growing list of third-party companies. This comes as a recent Expert Market Research (“EMR”) report projects that North America is likely to be the fastest-growing and largest marketplace for cannabis beverages and that the global market will grow at a 48% CAGR in the next five years. Thus, BevCanna is ideally situated. A recent article reads, “The…

TuesdayOct 12, 2021 3:07 pm

QualityStocksNewsBreaks – Ideanomics Inc. (NASDAQ: IDEX) Expands Talent Pool, Further Develops Strategic Advantage as Global EV Mobility Solutions Provider

Ideanomics (NASDAQ: IDEX) recently appointed Robin Mackie as the new president of Ideanomics Mobility, a division that offers access to industry leading products and services across vehicle procurement, charging infrastructure and energy management. Mackie, who previously served Ideanomics as a consultant for six months, brings three decades of experience in engineering, operations and global design in different highly regulated industries, including offshore, construction and automotive. In discussing the appointment, Ideanomics CEO Alf Poor noted that Robin has proven to be a driving force in his recent consulting role. “Bringing him onto our internal team in a leadership capacity will help…

TuesdayOct 12, 2021 2:57 pm

QualityStocksNewsBreaks – Avricore Health Inc.’s (TSX.V: AVCR) (OTCQB: AVCRF) Flagship Offering Helping Patients Take Steps to a Healthier Future

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is providing direct access to lab-accurate tests that measure and monitor conditions such as heart disease and diabetes, thereby leveraging health trends that note that consumers are increasingly taking health into their own hands. According to a recent McKinsey report, consumers are increasingly reliant on devices that help them monitor their own health and symptoms between doctor’s appointments. A recent article reads, “Through its flagship offering and wholly owned subsidiary, HealthTab(TM), the company turns pharmacies into community diagnostic centers by providing a turnkey point-of-care testing platform. The platform, which brings these analyzers into a…

MondayOct 11, 2021 2:22 pm

QualityStocksNewsBreaks – RYAH Group Inc. (CSE: RYAH) Providing Reliable, Consistent Dose Administration and Monitoring Devices

RYAH Group (CSE: RYAH), a connected device and big data and technology company, offers a suite of precision intake control and management devices that provide a practical way to execute volume control guidelines safely. In a company blog post, discussed in a recent article, RYAH noted that a global task force had created three separate dosing protocols: routine administration, conservative administration and rapid administration, with each designed to ease a patient treating chronic pain into medical cannabis and treatment with THC if needed. Such dosing guidelines are just half of the equation. The other half is the delivery mechanism, as…

MondayOct 11, 2021 1:40 pm

QualityStocksNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Stands Distinct in World of Cancer Prevention, Treatment

AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, is a proven early thought leader and developer of multi-cancer (also called pan-cancer) ideas and technology. “AnPac Bio is one of the first companies in the world to produce major theories and methods of multi-level, multi-parameter and multi-cancer screening. The innovative technology has opened up a new field in early cancer screening that is based on a biophysical property and has achieved significant results,” reads a recent article. AnPac Bio has one of the largest sample libraries in the world, with more than 220,000 samples…

MondayOct 11, 2021 1:26 pm

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Preparing for Clinical Trials Amid Growing Push for New Federally Approved Therapeutic

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) expects to soon launch a phase 2a clinical trial to determine the efficacy of its psychedelic drug candidate TRP-8802 in treating Prader-Willi Syndrome, hypothalamic obesity eating disorder resulting from removal of a brain tumor, and binge eating disorder. According to a recent article, TRP-8802 will be used in combination with psychotherapy under professional care to create the proper mindset for the neuroplasticity benefits of psilocybin to take full effect. Tryp then plans to proceed into phase 2b clinical trials with drug candidate TRP-8803 to test the trademarked product’s ability to penetrate the natural blood-brain…

MondayOct 11, 2021 1:08 pm

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Poised Amid New Research Surrounding Psilocybin

Cybin (NEO: CYBN) (NYSE American: CYBN), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, is likely to benefit from new research touting psilocybin mental health treatments. According to recent news from a group of Yale researchers, psilocybin has been found to counteract symptoms of depression (https://ibn.fm/NCORl). “Yale researchers found that a single dose of the naturally occurring psychedelic compound psilocybin can cause structural changes in the brain that counteract symptoms of depression,” reads a recent article quoting a Yale Daily News publication titled “Yale Researchers Discover Healing Effects of Psychedelic Drug.” In the piece published…

MondayOct 11, 2021 12:11 pm

QualityStocksNewsBreaks – PlantX Life Inc.’s (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Unveiling of Squamish ‘XMarket’ to Feature Vegan Barbecue, New Mural and High-Profile Ambassadors

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) has marked many recent achievements and is focused on completing several key milestones for a strong remainder of the 2021 fiscal year. Among these, PlantX is focused on an ongoing retail branding initiative to rename its existing brick-and-mortar stores as “XMarket.” The new identity intends to reflect the dynamic, interactive and diverse in-store experience provided by the company’s physical retail locations. Currently, PlantX has physical stores in British Columbia, Squamish, and Venice Beach, California, all of which will be re-branded as XMarket. “The official unveiling of XMarket in Squamish, British Columbia,…

MondayOct 11, 2021 12:00 pm

QualityStocksNewsBreaks – InnerScope Hearing Technologies Inc. (INND) Helping People Get Hearing Aids at Fraction of Cost

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer (“DTC”) hearing technology space, is committed to changing the lives of millions of Americans with hearing impairment, helping them get the hearing aids they need at a fraction of the cost set by traditional hearing clinics. “The costs of one hearing aid alone can range from $1,000 to as much as $6,000, not including additional expenses that can occur, such as hearing tests, follow-ups and ongoing support from healthcare professionals,” reads a recent article. One of the key drivers of these prohibitive costs is that consumers must…

Site Search

Company Search

Category: Stock Spotlight